Patents by Inventor Abu Syed Md Anisuzzaman

Abu Syed Md Anisuzzaman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting Mcl-1 to Enhance DNA Replication Stress Sensitivity for Cancer Therapy
    Publication number: 20230060792
    Abstract: This disclosure relates to inhibitors of Mcl-1 stimulated homologous recombination (HR) DNA repair and uses for treating cancer. In certain embodiments, this disclosure relates to methods of treating cancer comprising administering an inhibitor of Mcl-1 in combination with other anti-cancer agents, e.g., that induce DNA replication stress. In certain embodiments, this disclosure relates to methods of treating cancer comprising administering compounds disclosed herein in combination with hydroxyurea, olaparib, or combinations thereof.
    Type: Application
    Filed: October 28, 2022
    Publication date: March 2, 2023
    Inventors: Xingming Deng, Guo Chen, Abu Syed Md Anisuzzaman
  • Targeting Mcl-1 to enhance DNA replication stress sensitivity for cancer therapy
    Patent number: 11524000
    Abstract: This disclosure relates to inhibitors of Mcl-1 stimulated homologous recombination (HR) DNA repair and uses for treating cancer. In certain embodiments, this disclosure relates to methods of treating cancer comprising administering an inhibitor of Mcl-1 in combination with other anti-cancer agents, e.g., that induce DNA replication stress. In certain embodiments, this disclosure relates to methods of treating cancer comprising administering compounds disclosed herein in combination with hydroxyurea, olaparib, or combinations thereof.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: December 13, 2022
    Assignee: Emory University
    Inventors: Xingming Deng, Guo Chen, Abu Syed Md Anisuzzaman
  • Targeting Mcl-1 to Enhance DNA Replication Stress Sensitivity for Cancer Therapy
    Publication number: 20200316011
    Abstract: This disclosure relates to inhibitors of Mcl-1 stimulated homologous recombination (HR) DNA repair and uses for treating cancer. In certain embodiments, this disclosure relates to methods of treating cancer comprising administering an inhibitor of Mcl-1 in combination with other anti-cancer agents, e.g., that induce DNA replication stress. In certain embodiments, this disclosure relates to methods of treating cancer comprising administering compounds disclosed herein in combination with hydroxyurea, olaparib, or combinations thereof.
    Type: Application
    Filed: October 23, 2018
    Publication date: October 8, 2020
    Inventors: Xingming Deng, Guo Chen, Abu Syed Md Anisuzzaman